Skip to main content

ProShares Trust II

For the period ended Dec 31, 2025. Filed Feb 26, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 26, 2026

SCO$20.19+2.3%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

ProShares Ultra Yen

December 31, 2025December 31, 2024
Assets
Cash$43,846,101$39,802,626
Segregated cash balances with brokers for foreign currency forward contracts5,912,0138,805,479
Unrealized appreciation on foreign currency forward contracts1,161146,194
Interest receivable128,447149,992
Total assets49,887,72248,904,291
Liabilities and shareholders’ equity
Liabilities
Payable to Sponsor38,56337,154
Unrealized depreciation on foreign currency forward contracts1,183,8094,361,491
Total liabilities1,222,3724,398,645
Commitments and Contingencies (Note 2)
Shareholders’ equity
Shareholders’ equity48,665,35044,505,646
Total liabilities and shareholders’ equity$49,887,722$48,904,291
Shares outstanding2,549,9702,199,970
Net asset value per share$19.08$20.23
Market value per share (Note 2)$19.06$20.35

^

Settlement DateContract Amount in Local CurrencyContract Amount in U.S. DollarsUnrealized Appreciation (Depreciation)/ Value
Contracts to Purchase
Yen with Goldman Sachs International01/09/267,816,408,056$49,927,018$(582,024)
Yen with UBS AG01/09/267,934,232,85650,679,619(601,785)
Total Unrealized Depreciation$(1,183,809)
Contracts to Sell
Yen with UBS AG01/09/26(463,767,000)$(2,962,294)$1,161
Total Unrealized Appreciation$1,161
^The positions and counterparties herein are as of December 31, 2025. The Fund continually evaluates different counterparties for their transactions and counterparties are subject to change. New counterparties can be added at any time.

^

Settlement DateContract Amount in Local CurrencyContract Amount in U.S. DollarsUnrealized Appreciation (Depreciation)/ Value
Contracts to Purchase
Yen with Goldman Sachs International01/10/257,308,549,056$46,506,241$(2,180,271)
Yen with UBS AG01/10/257,519,501,85647,848,591(2,181,220)
Total Unrealized Depreciation$(4,361,491)
Contracts to Sell
Yen with Goldman Sachs International01/10/25(66,274,000)$(421,719)$16,187
Yen with UBS AG01/10/25(730,519,000)(4,648,486)130,007
Total Unrealized Appreciation$146,194
^The positions and counterparties herein are as of December 31, 2024. The Fund continually evaluates different counterparties for their transactions and counterparties are subject to change. New counterparties can be added at any time.
Year Ended December 31,
202520242023
Investment Income
Interest$2,040,523$1,853,973$667,026
Expenses
Management fee543,420405,325145,536
Total expenses543,420405,325145,536
Net investment income (loss)1,497,1031,448,648521,490
Realized and unrealized gain (loss) on investment activity
Net realized gain (loss) on
Foreign currency forward contracts(6,455,940)(6,562,004)(2,637,502)
Net realized gain (loss)(6,455,940)(6,562,004)(2,637,502)
Change in net unrealized appreciation (depreciation) on
Foreign currency forward contracts3,032,649(5,734,582)534,736
Change in net unrealized appreciation (depreciation)3,032,649(5,734,582)534,736
Net realized and unrealized gain (loss)(3,423,291)(12,296,586)(2,102,766)
Net income (loss)$(1,926,188)$(10,847,938)$(1,581,276)

F-

Year Ended December 31,
202520242023
Shareholders’ equity, beginning of period$44,505,646$30,205,770$13,814,796
Addition of 1,500,000, 2,050,000 and 1,000,000 shares, respectively31,666,87848,124,28127,033,889
Redemption of 1,150,000, 950,000 and 300,000 shares, respectively(25,580,986)(22,976,467)(9,061,639)
Net addition (redemption) of 350,000, 1,100,000 and 700,000 shares, respectively6,085,89225,147,81417,972,250
Net investment income (loss)1,497,1031,448,648521,490
Net realized gain (loss)(6,455,940)(6,562,004)(2,637,502)
Change in net unrealized appreciation (depreciation)3,032,649(5,734,582)534,736
Net income (loss)(1,926,188)(10,847,938)(1,581,276)
Shareholders’ equity, end of period$48,665,350$44,505,646$30,205,770
Year Ended December 31,
202520242023
Cash flow from operating activities
Net income (loss)$(1,926,188)$(10,847,938)$(1,581,276)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Change in unrealized (appreciation) depreciation on investments(3,032,649)5,734,582(534,736)
Decrease (Increase) in interest receivable21,545(45,451)(65,337)
Increase (Decrease) in payable to Sponsor1,40914,55411,685
Net cash provided by (used in) operating activities(4,935,883)(5,144,253)(2,169,664)
Cash flow from financing activities
Proceeds from addition of shares31,666,87848,124,28127,033,889
Payment on shares redeemed(25,580,986)(24,349,634)(7,688,472)
Net cash provided by (used in) financing activities6,085,89223,774,64719,345,417
Net increase (decrease) in cash1,150,00918,630,39417,175,753
Cash, beginning of period48,608,10529,977,71112,801,958
Cash, end of period$49,758,114$48,608,105$29,977,711
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.